免疫系统
癌症研究
肿瘤微环境
癌相关成纤维细胞
乳腺癌
生物
油酸
癌症
细胞毒性T细胞
PD-L1
细胞毒性
医学
免疫学
癌细胞
代谢途径
代谢活性
信号转导
分泌物
后天抵抗
串扰
细胞因子
细胞
细胞培养
作者
Peicheng Jiang,Xinyan Li,Ziyi Wang,S Li,Yonglian Huang,Ye-Xiong Li,Yuqiong Chen,Xiangyu Sun
标识
DOI:10.1038/s41698-026-01338-9
摘要
Chemoresistance remains a critical challenge in breast cancer (BC) treatment. By integrating multi-omics (single-cell, spatial, and bulk transcriptomics) with clinical validation, we identified a specific COL3A high CAF subset that drives BC chemoresistance. Mechanistically, these CAFs undergo lipid metabolic reprogramming, secreting excess oleic acid via SCD. This oleic acid binds to ENO1 on tumor cells, activating the PI3K/Akt pathway and inhibiting chemotherapy-induced apoptosis. Simultaneously, COL3A high CAFs orchestrate an immunosuppressive niche by recruiting regulatory T cells and impairing cytotoxic CD8 + T cells. Our findings establish COL3A high CAFs as key mediators of resistance through metabolic symbiosis and immune evasion. The strong correlation between COL3A high CAF abundance and clinical poor response highlights their potential as both predictive biomarkers and therapeutic targets to overcome chemoresistance in BC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI